https://cynarininhibitor.com/p....reoperative-solution
Three studies reported histopathological proof of previous treatment reaction. There have been two treatment relevant deaths at ninety days. Median survival had been 19 (95% CI 9.9-28) months and 5-year success 20%. CONCLUSIONS you can find possible advantages of therapy on both R0 rate and complete response in resected specimens. Scientific equipoise is present with regards to neoadjuvant chemoradiotherapy for PH-CCA. V.PURPOSE The purpose of this study was to assess t
Like
Comment
Share
